Pelle from Sweden

Registered at the short selling broker Skilling, 4 minutes ago.

» Try Skilling you too
69% of retail CFD accounts lose money.
Don't show again

Johnson & Johnson (JNJ) shares information

Johnson & Johnson

24h Change

-0.43 %


Live rate: Market closed

Stock data per Wednesday 21 Oct, 2020

New York Stock Exchange
-0.62 (-0.43%)
US Market is closed

Live Stock price in graph for Johnson & Johnson (JNJ)

  • Latest Volume

    5,221,348 (-1.97 %)

  • Volume prev. day


  • Avg. daily volume


  • Market cap


  • P/E ratio


  • Today high


  • Today low


  • 52 week high


  • 52 week low


  • YTD Change


Quick links

Broker recommendations for Johnson & Johnson

The Johnson & Johnson stock is rated at 1.388889 (on a scale 1-3, where 1 is ‘strong buy‘ and 3 is ‘strong sell‘) from Wednesday 14 October, 2020 by a total of 18 brokers. This means that the consensus of the 18 different brokers is leaning toward to buy/moderate buy.

0 (0%)
0 (0%)
6 (33.33%)
2 (11.11%)
10 (55.56%)

Price target by analysts

The 16 latest analyst estimates, per Wednesday 14 October, 2020, show the following high, low and average price targets.
Target Average: 166.55 USD
Target High: 180 USD
Target Low: 139 USD


Latest news about Johnson & Johnson

Below you can find the most recent news posts about Johnson & Johnson, primarily from US and UK based news sources.

Self-Monitoring of Blood Glucose Market With Leading Players like Lifescan, Ascensia, Arkray, Abbott, F. Hoffmann-La Roche AG, Dexcom, Johnson and Johnson, Medtronic, Ascensia Diabetes Care Holdings AG, B. Barun Melsungen AG

Thursday, 22 October 2020, 08:34:50
Monitoring blood glucose is an important diabetes management step. Blood glucose tracking systems are primarily used to monitor a patient’s blood glucose level. Self-monitoring blood glucose (SMBG) devices are easy-to-use and allow users to monitor their blood glucose level regardless
— OpenPR

Head of Operation Warp speed says he expects coronavirus vaccine trials to resume next week

Wednesday, 21 October 2020, 23:44:52
Both AstraZeneca Plc – in conjunction with University of Oxford – and Johnson & Johnson placed their coronavirus vaccine trials on hold after patients developed unexplained illnesses.
— Daily Mail Online

Johnson & Johnson stock falls Wednesday, underperforms market

Wednesday, 21 October 2020, 22:25:00
COMPANY CLOSE UPDATES Terrence Horan Shares of Johnson & Johnson JNJ slumped 0.43% to $143.93 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.
— Yahoo Finance

EU Signed Contract With Johnson & Johnson on Up to 400Mln Doses of COVID-19 Vaccine

Wednesday, 21 October 2020, 12:30:07
No summary available.
— UrduPoint

Point of Care Diagnostics Market Top-Companies, Future-Growth, Regional Analysis, Business-Opportunities 2027 | Abbott, Siemens, Johnson & Johnson, Sysmex Corporation, Nova Biomedical

Wednesday, 21 October 2020, 11:28:30
Rising prevalence of various infectious diseases and several initiatives implemented by government and non-government associations for rise in health awareness around the world are the factors majorly driving the point of care diagnostics market growth. The technological advancements in point
— OpenPR

Trading broker recommendation

We recommend that you check out as they have a very good selection of stocks available for both going short and long.

Rating: 9.57/10
Minimum deposit: €/$ 20
Description: offer a large number of stocks for trading. Register an account today and check if they have JNJ available or trade one of the many other CFD stocks they have.
Risk warning: 75% of retail investor accounts lose money when trading CFDs with Capital.